Options for UK Technetium-99m production using accelerators

H. L. Owen, J. Ballinger, J. Buscombe, R. Clarke, E. Denton, B. Ellis, G. Flux, L. Fraser, B. Neilly, A. Paterson, A. C. Perkins, A. Scarsbrook

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

1 Citation (Scopus)

Abstract

Recent and ongoing shortages in reactor-based supplies of molybdenum-99 for hospital production of the important medical radioisotope Technetium-99m have prompted the re-examination of the alternative production methods using conventional and laser-based particle accelerators. At present the UK has no domestic source of molybdenum-99 and relies exclusively on overseas supply; the National Health Service, with professional partners, is therefore examining the options for domestic production of molybdenum-99 and/or technetium-99m to increase security of supply. In this paper we review the accelerator-based methods from a UK perspective, and outline the most promising methods for short- and medium-term supply, which include low-energy cyclotron and photonuclear reaction routes using enriched Molybdenum-100 targets.

Original languageEnglish
Title of host publicationIPAC 2014
Subtitle of host publicationProceedings of the 5th International Particle Accelerator Conference
PublisherJoint Accelerator Conferences Website (JACoW)
Pages2815-2818
Number of pages4
ISBN (Electronic)9783954501328
Publication statusPublished - 1 Jul 2014
Event5th International Particle Accelerator Conference, IPAC 2014 - Dresden, Germany
Duration: 15 Jun 201420 Jun 2014

Publication series

NameIPAC 2014: Proceedings of the 5th International Particle Accelerator Conference

Conference

Conference5th International Particle Accelerator Conference, IPAC 2014
Country/TerritoryGermany
CityDresden
Period15/06/1420/06/14

Bibliographical note

Publisher Copyright:
Copyright © 2014 CC-BY-3.0 and by the respective authors.

Fingerprint

Dive into the research topics of 'Options for UK Technetium-99m production using accelerators'. Together they form a unique fingerprint.

Cite this